Axsome Therapeutics, Inc. short interest in 2020
In 2020, Axsome Therapeutics, Inc.'s disclosed short interest ran from 11.55% of shares outstanding on 15 Jan 2020 to 9.27% on 31 Dec 2020, a change of -2.28 percentage points. The year's high was 11.78% on 31 Jan 2020 and its low 8.94% on 30 Nov 2020, averaging 10.17% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.93 days on 30 Nov 2020. Full history: Axsome Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 11.55% (15 Jan 2020)
- End of year
- 9.27% (31 Dec 2020)
- Change
- -2.28 pp
- High
- 11.78% (31 Jan 2020)
- Low
- 8.94% (30 Nov 2020)
- Average
- 10.17%
- Highest days to cover
- 16.93 (30 Nov 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 11.55% | 3.69 | |
| 31 Jan 2020 | 11.78% | 7.25 | |
| 14 Feb 2020 | 11.43% | 7.08 | |
| 28 Feb 2020 | 10.97% | 5.34 | |
| 13 Mar 2020 | 11.22% | 5.46 | 10-K filed, results (8-K) |
| 31 Mar 2020 | 10.50% | 3.01 | |
| 15 Apr 2020 | 11.39% | 4.98 | |
| 30 Apr 2020 | 9.67% | 2.85 | |
| 15 May 2020 | 9.24% | 5.20 | results (8-K), 10-Q filed |
| 29 May 2020 | 9.16% | 6.60 | |
| 15 Jun 2020 | 9.56% | 8.09 | |
| 30 Jun 2020 | 10.40% | 5.58 | |
| 15 Jul 2020 | 10.43% | 10.48 | |
| 31 Jul 2020 | 10.43% | 12.40 | |
| 14 Aug 2020 | 10.40% | 11.30 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 10.31% | 13.99 | |
| 15 Sep 2020 | 9.84% | 7.69 | |
| 30 Sep 2020 | 10.25% | 8.37 | |
| 15 Oct 2020 | 9.71% | 14.88 | |
| 30 Oct 2020 | 9.23% | 14.49 | |
| 13 Nov 2020 | 9.26% | 11.20 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 8.94% | 16.93 | |
| 15 Dec 2020 | 9.05% | 9.30 | |
| 31 Dec 2020 | 9.27% | 11.13 |
See also: Axsome Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.